AstraZeneca launches human tests for bird flu vaccines
NCT ID NCT07128615
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests two experimental vaccines, AZD4117 and AZD5315, designed to protect against certain strains of avian influenza (bird flu), specifically H5N1 and H7N9. Around 405 healthy adults will receive either a vaccine or a placebo to see if the vaccines are safe and trigger a strong immune response. The trial is currently active but not recruiting new participants.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AZD4117 and AZD5315 vaccines
What this could lead to
If successful, these vaccines could help protect people against certain bird flu strains, potentially preventing a future pandemic.
What could go wrong
This is an early-phase trial focused on safety and immune response, not yet proven to prevent infection. The vaccines may not work as hoped or could cause side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA A are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Long Beach, California, 90815, United States
-
Research Site
Rolling Hills Estates, California, 90274, United States
-
Research Site
Hialeah, Florida, 33012, United States
-
Research Site
Stockbridge, Georgia, 30281, United States
-
Research Site
Chicago, Illinois, 60640, United States
-
Research Site
Lenexa, Kansas, 66219, United States
-
Research Site
Kansas City, Missouri, 64114, United States
-
Research Site
Omaha, Nebraska, 68134, United States
-
Research Site
Las Vegas, Nevada, 89119, United States
-
Research Site
Cincinnati, Ohio, 45212, United States
-
Research Site
Edmond, Oklahoma, 73013, United States
-
Research Site
North Charleston, South Carolina, 29405, United States
-
Research Site
Austin, Texas, 78745, United States
-
Research Site
West Jordan, Utah, 84088, United States